| 12 | $CGXEF News Article - CGX Energy Announces Chief | whytestocks | 07/18/2022 2:05:53 PM |
| 11 | $CGXEF News Article - CGX And Frontera Announce | whytestocks | 05/09/2022 11:10:49 AM |
| 10 | AGYP a Domestic Driller in Prime Position to | lortscherunser | 03/11/2022 7:40:01 AM |
| 9 | $CGXEF News Article - CGX Energy Inc. and |
whytestocks | 12/16/2021 10:15:53 AM |
| 8 | $CGXEF News Article - CGX Energy Provides | whytestocks | 07/12/2021 3:50:49 PM |
| 7 | CGXEF 31% v1,9M c2.19 f287M H2.2 what a month | znewcar1 | 06/25/2021 6:37:53 PM |
| 6 | $CGXEF News Article - CGX Energy Announces | whytestocks | 04/22/2021 10:45:48 AM |
| 5 | CGXEF 46% v1,1M c.66 f232M | znewcar1 | 08/28/2019 4:33:07 PM |
| 4 | CGXEF Financials 07/16/2014 11:29:47 CGX Energy | Emylers | 07/16/2014 12:29:43 PM |
| 3 | Latest Cgx Energy Inc (CGXEF) Headlines Pacific | Stock_Tracker | 03/09/2014 7:31:10 AM |
| 2 | CGXEF 0.209 Stock Charts $CGXEF 1 Month Chart | chartguy89 | 03/06/2014 9:59:16 AM |
| 1 | CGXEF Stock Charts Monday, February 24, 2014 at | chartguy89 | 02/24/2014 10:51:12 AM |
Recent Articles
- Transformative Cancer Vaccine EVX-04 Shines at Major Meeting
- Exploring Recent Advancements in CARVYKTI and LUCAR-G39D Therapies
- Unraveling Market Disconnects: Investment Opportunities Ahead
- Shaquille O'Neal's Basketball Journey: From Reebok to Walmart
- Urgent Appeal for Ongoing Hepatitis B Vaccination in Newborns
- Copper Property CTL Trust Monthly Update for November 2025
- Elon Musk's Inspiring Advice for Aspiring Innovators
- Investigation of Major Mergers: A Look into Four Corporations
- How Chad IDE is Transforming Developer Productivity Today
- BexBack Unveils Exciting $100 Welcome Bonus for Traders
- Ray Dalio's Humble Beginnings: A Lesson in Resilience
- Lundbeck's Bexicaserin Shows Promise in Managing Childhood Epilepsies
- Lundbeck Unveils Positive Findings on Bexicaserin for Unique Epilepsies
- RadiantVibe Capital Unveils Insight Access Dashboard Initiative
- Kevin O'Leary's Formula for Financial Success: The $5M Rule
- Educators Unite for a Brighter Future at the Yidan Summit
- Elon Musk's Response to EU's $140 Million Penalty on X
- Copper Market Perspectives: Bullish Trends Amidst Contrasting Views
- Prelude Therapeutics Unveils Innovative MPN Treatment Breakthrough
- Current Trends in Cryptocurrency Markets: BTC, DOGE, ETH Updates
- Former MrBeast Creator Launches AI Platform for Content
- LiberNovo Launches Revolutionary Ergonomic Chair Globally
- LiberNovo Launches Omni Ergonomic Chair in European Market
- Blokees Unveils Exciting New Products at Major Comic Event
- Jensen Huang Reflects on Partnership with Elon Musk and Tesla
- Significant Progress in CLL Treatment with Lisaftoclax Insights
- New Findings on Lisaftoclax at ASH Annual Meeting 2025
- Marjorie Taylor Greene Opens Up About Trump and Political Rift
- Opportunity for Sprouts Farmers Market Investors Amid Legal Actions
- Labor Management Systems: A Pathway to Workforce Optimization
- Dave Ramsey Encourages Workers to Seek Fulfillment Elsewhere
- Perrigo Company Faces Class Action: Key Details for Investors
- Breakthrough CAR-T Therapy Shows Promise in Non-Hodgkin's Lymphoma
- CARVYKTI® Shows Promising Long-Term Remission Rates in Myeloma
- Exploring the Upcoming Boom in In-Memory Database Solutions
- System Infrastructure Software Market Expected to Surge by 2032
- Genmab's Epcoritamab Shows Promising Results in Trials
- Nurix Therapeutics Advances Bexobrutideg for CLL Patients
- Cogent Biosciences Unveils SUMMIT Study Insights on Bezuclastinib
- Class Action Lawsuit Filed Against Blue Owl Capital: Key Info
- Promising Phase 1 Results of Bexobrutideg for CLL Patients
- Cogent Biosciences Shares SUMMIT Trial Outcomes on Bezuclastinib
- Top 5 Trending Stocks: Insights on META, NFLX, and More
- CARVYKTI® Shows Promise in Long-Term Remission of Myeloma
- Concerns Rise Over ALT5 Sigma's Financial Stability and Audit Issues
- Education Leaders Unite for Change at Yidan Prize Summit 2025
- Projected Growth of Peptide Therapeutics Market by 2032
- Marex Stockholder Alert: Important Legal Deadline Approaching
- Comparative Analysis of MP Materials and USA Rare Earth Investment Prospects
- Viatris Sells Equity Stake in Biocon Biologics for $815 Million
